Deep TMS vs Standard TMS: What Patients Should Know

For someone living with depression that has not improved enough with medication, therapy, or both, the question of deep TMS vs standard TMS can feel highly personal. Both are noninvasive forms of transcranial magnetic stimulation that use magnetic pulses to stimulate brain circuits involved in mood. Neither requires surgery, anesthesia, or sedation. The right choice depends less on finding a universally “better” treatment and more on matching an evidence-based protocol to your diagnosis, treatment history, symptoms, and practical needs.

What TMS treatment is designed to do

TMS is an FDA-cleared treatment approach that uses a magnetic coil placed against the scalp. The coil produces brief magnetic pulses that pass through the skull and influence targeted areas of the brain. For depression, treatment often focuses on the left dorsolateral prefrontal cortex, a region involved in mood regulation, motivation, attention, and emotional processing.

Depression is not caused by a single brain region working incorrectly. It is a complex condition involving networks that communicate across the brain, as well as psychological, medical, social, and biological factors. TMS is not intended to replace thoughtful psychiatric care. It can be an important part of a broader plan that may also include medication management, psychotherapy, sleep support, and strategies for managing stress and daily functioning.

TMS is often considered when antidepressant medication has not provided adequate relief, has caused difficult side effects, or is not a good fit for the patient. Some people pursue it because they want a treatment that does not have the systemic effects commonly associated with medication. That does not mean medication is inherently the wrong choice. It means treatment planning should be individualized.

Deep TMS vs standard TMS: the key difference

The main difference is the coil design and the pattern of magnetic stimulation it produces.

Standard TMS, sometimes called conventional or figure-8 TMS, typically uses a figure-8-shaped coil. This design allows clinicians to focus stimulation relatively precisely at a selected cortical target near the surface of the brain. Standard TMS has a substantial evidence base for major depressive disorder, and it has been used in several protocol variations, including accelerated and shorter-session approaches when clinically appropriate.

Deep TMS uses an H-coil, which is designed to stimulate a broader area and reach somewhat deeper into cortical networks than a conventional figure-8 coil. “Deep” can be misleading if it suggests that the treatment reaches every deep brain structure or that it is an invasive procedure. It does not. Deep TMS remains an outpatient, noninvasive treatment delivered from outside the head.

The wider field produced by an H-coil may be useful for certain patients and indications, but broader stimulation is not automatically superior. A more focal approach can also be clinically valuable when a specific target and protocol are appropriate. The meaningful question is not simply how far the magnetic field reaches. It is whether the chosen device, target, and treatment schedule fit the condition being treated.

FDA clearance and treatment indications

Both standard TMS and Deep TMS are supported by FDA-cleared devices and protocols. However, clearance applies to particular devices and clinical indications, not to every possible use of TMS.

For example, Deep TMS has FDA-cleared protocols for major depressive disorder and obsessive-compulsive disorder. Standard TMS devices also have FDA-cleared protocols for depression, and certain devices and protocols have clearance for additional conditions. A psychiatrist should explain whether the proposed treatment is FDA-cleared for your diagnosis, as well as whether any off-label recommendation is being considered and why.

This distinction matters because TMS is not a one-size-fits-all intervention. A person with treatment-resistant depression, depression with significant anxiety, or OCD symptoms may need a different target, protocol, or overall care plan.

What treatment sessions feel like

Most patients remain awake and seated in a treatment chair throughout TMS. Before treatment begins, the clinical team identifies the appropriate stimulation location and determines an individual motor threshold. This is a measurement used to guide dosing safely and accurately.

During a session, patients hear repetitive clicking and may feel tapping, knocking, or tightening sensations on the scalp. Standard TMS can feel more focal at the treatment site, while Deep TMS may create a broader sensation. Comfort is subjective. Some people find either treatment mildly uncomfortable at first, particularly around the forehead or scalp, but the sensation often becomes easier to tolerate as they adjust.

A common short-term side effect is headache or scalp discomfort. These symptoms are usually mild to moderate and often improve with adjustments to coil positioning, intensity, or simple measures recommended by the treating clinician. TMS does not typically cause the memory problems associated with electroconvulsive therapy. Although the risk is low, seizure is a known potential risk, which is why a careful psychiatric and medical screening is essential.

Scheduling can differ, but consistency matters most

Traditional TMS treatment for depression often involves weekday sessions over several weeks. Session length varies substantially depending on the device and protocol. Some conventional protocols take longer, while certain intermittent theta burst stimulation protocols can be completed in only a few minutes of active stimulation. Deep TMS sessions may also be relatively brief, though the overall appointment includes preparation and positioning.

The total number of treatments is not the only factor that matters. Consistency, appropriate dosing, and clinical monitoring all affect the quality of care. For New Yorkers balancing demanding work, school, parenting, and commuting, scheduling may influence which option is realistically sustainable. A treatment plan only works if it can be completed safely and reliably.

Insurance coverage also varies by plan, diagnosis, prior treatment history, device, and documentation requirements. Many insurers require evidence that depression has not responded adequately to prior medication trials and sometimes psychotherapy. It is reasonable to ask early about anticipated coverage, authorization steps, out-of-pocket costs, and what happens if a treatment schedule needs to change.

Is Deep TMS more effective than standard TMS?

There is no responsible universal answer. Both approaches can help people with depression, including individuals whose symptoms have persisted despite prior treatment. Clinical studies support each modality, but research comparisons are affected by differences in patient populations, targets, stimulation schedules, outcome measures, and the definition of response or remission.

For one patient, Deep TMS may be a strong option because of the diagnosis, the availability of an FDA-cleared protocol, or a clinician’s assessment of the relevant symptom pattern. For another, standard figure-8 TMS may offer a more suitable treatment target or a preferred protocol. Prior treatment history matters as well. Someone who did not improve with one TMS course may still benefit from a careful reassessment rather than assuming all TMS will have the same result.

It is also helpful to set realistic expectations. Some patients notice changes in energy, concentration, sleep, or emotional reactivity before their mood fully improves. Others experience a more gradual shift over several weeks. Not everyone responds, and improvement can be partial rather than complete. When symptoms begin to improve, ongoing psychiatric care can help consolidate those gains and address the patterns that may continue to affect mood.

How a psychiatrist helps determine the right approach

A quality TMS evaluation is more than a device comparison. It begins with confirming the diagnosis and understanding how depression is affecting work, relationships, motivation, sleep, appetite, concentration, and safety. The evaluation should also review previous medications, therapy experiences, medical conditions, substance use, current medications, and any history that could affect TMS safety.

Your psychiatrist may also consider whether anxiety, OCD, ADHD, trauma-related symptoms, bipolar spectrum symptoms, or other conditions are contributing to the clinical picture. For example, someone whose low mood is connected to untreated bipolar disorder needs a different treatment strategy than someone with unipolar major depression. TMS may still be discussed in some complex cases, but only within careful diagnostic and medication management.

Questions worth bringing to a consultation include which protocol is recommended, why it fits your symptoms, how progress will be measured, and what alternatives are available if improvement is limited. You should also understand how TMS will coordinate with current therapy and medication treatment rather than exist as an isolated service.

The choice between Deep TMS and standard TMS should leave you with more clarity, not more pressure. A careful evaluation can identify whether TMS is appropriate and help build a plan that treats depression with the clinical precision and compassion lasting improvement requires.